140 related articles for article (PubMed ID: 38324164)
21. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
[TBL] [Abstract][Full Text] [Related]
22. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
[TBL] [Abstract][Full Text] [Related]
23. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
Martins A; Gonçalves A; Almeida T; Midões A
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
[TBL] [Abstract][Full Text] [Related]
24. ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus.
Giannetta E; Guarnotta V; Altieri B; Sciammarella C; Guadagno E; Malandrino P; Puliani G; Feola T; Isidori AM; Colao AAL; Faggiano A
Eur J Endocrinol; 2020 Dec; 183(6):R197-R215. PubMed ID: 33112280
[TBL] [Abstract][Full Text] [Related]
25. Unusual gastric mucosal infiltration by a medullary thyroid carcinoma: a case report.
Karrasch T; Doppl W; Roller FC; Schäffler A; Schäffer R; Gattenlöhner S
J Med Case Rep; 2016 Jul; 10():208. PubMed ID: 27461534
[TBL] [Abstract][Full Text] [Related]
26. False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
Takeshima K; Ariyasu H; Uraki S; Morita S; Furukawa Y; Inaba H; Iwakura H; Doi A; Warigaya K; Murata SI; Enomoto K; Hotomi M; Akamizu T
Endocr J; 2020 Oct; 67(10):1007-1017. PubMed ID: 32522910
[TBL] [Abstract][Full Text] [Related]
27. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
Murphy DC; Johnson SJ; Aspinall S
Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
[TBL] [Abstract][Full Text] [Related]
28. Novel acquisitions in the diagnosis of medullary thyroid carcinoma.
Trimboli P; Crescenzi A; Saggiorato E; Treglia G; Giovanella L
Minerva Endocrinol; 2017 Sep; 42(3):238-247. PubMed ID: 27808486
[TBL] [Abstract][Full Text] [Related]
29. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: the diagnostic importance of CGRP immunoreactivity.
Nakazawa T; Cameselle-Teijeiro J; Vinagre J; Soares P; Rousseau E; Eloy C; Sobrinho-Simões M
Int J Surg Pathol; 2014 Sep; 22(6):530-5. PubMed ID: 24599901
[TBL] [Abstract][Full Text] [Related]
30. Procalcitonin measurement to screen medullary thyroid carcinoma: A prospective evaluation in a series of 2705 patients with thyroid nodules.
Giovanella L; Imperiali M; Piccardo A; Taborelli M; Verburg FA; Daurizio F; Trimboli P
Eur J Clin Invest; 2018 Jun; 48(6):e12934. PubMed ID: 29635700
[TBL] [Abstract][Full Text] [Related]
31. Non-functional water clear cell parathyroid carcinoma masquerading as medullary thyroid carcinoma.
Khalil M; Zafereo M; Gule-Monroe M; Sherman SI; Bell D
Ann Diagn Pathol; 2021 Oct; 54():151791. PubMed ID: 34293707
[TBL] [Abstract][Full Text] [Related]
32. [Routine serum calcitonin measurement in thyroid nodules].
Storani ME; Bostico ST; Subies FA; Musich M; Oneto A
Medicina (B Aires); 2019; 79(4):271-275. PubMed ID: 31487246
[TBL] [Abstract][Full Text] [Related]
33. Micro-medullary thyroid carcinoma: a diagnosis not to be missed.
Lacout A; Isaac S; Marcy PY
Postgrad Med J; 2015 Apr; 91(1074):236-7. PubMed ID: 25862709
[No Abstract] [Full Text] [Related]
34. Management of Medullary Thyroid Cancer.
Viola D; Elisei R
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):285-301. PubMed ID: 30717909
[TBL] [Abstract][Full Text] [Related]
35. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
[TBL] [Abstract][Full Text] [Related]
36. Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients' carcinoma death.
Ito Y; Miyauchi A; Kihara M; Kudo T; Miya A
Endocr J; 2016 Jul; 63(7):663-7. PubMed ID: 27097545
[TBL] [Abstract][Full Text] [Related]
37. Thresholds of Basal- and Calcium-Stimulated Calcitonin for Diagnosis of Thyroid Malignancy.
Băetu M; Olariu CA; Stancu C; Caragheorgheopol A; Ioachim D; Moldoveanu G; Corneci C; Badiu C
Horm Metab Res; 2021 Dec; 53(12):779-786. PubMed ID: 34687025
[TBL] [Abstract][Full Text] [Related]
38. Incidental Finding of Medullary Thyroid Carcinoma Metastasised to Cervical Nodes in a Neck Dissection Specimen.
Thong G; Doody J; Barry C; Timon C; Lennon P
Ir Med J; 2019 Feb; 112(2):877. PubMed ID: 30896138
[No Abstract] [Full Text] [Related]
39. Oncocytic variant of medullary thyroid carcinoma; a rare tumor with numerous diagnostic mimics by fine needle aspiration.
Sams SB; Tompkins KD; Mayson S; Raeburn CD; Mehrotra S
Diagn Cytopathol; 2017 Dec; 45(12):1148-1152. PubMed ID: 28802094
[TBL] [Abstract][Full Text] [Related]
40. Baseline and stimulated calcitonin: Thresholds for the diagnosis of medullary thyroid cancer.
Fugazzola L
Ann Endocrinol (Paris); 2019 Jun; 80(3):191-192. PubMed ID: 31053250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]